60 DEGREES PHARMACEUTICALS INC. - COMMON STOCK
0.2249
17-5月-24 15:59:55
15 分の遅延
株式
+0.0019
+0.85%
本日の幅
0.2200 - 0.2545
ISIN
N/A
ソース
NASDAQ
-
60 Degrees Pharmaceuticals Announces First Quarter 2024 Results
15 5 2024 13:45:03 提供 Nasdaq GlobeNewswire
-
08 5 2024 07:59:00 提供 Nasdaq GlobeNewswire
-
02 5 2024 07:59:00 提供 Nasdaq GlobeNewswire
-
60 Degrees Pharmaceuticals to Sponsor Pilot Study of Tafenoquine for Treatment of Canine Babesiosis
03 4 2024 07:58:00 提供 Nasdaq GlobeNewswire
-
14 3 2024 07:59:00 提供 Nasdaq GlobeNewswire
-
20 2 2024 07:59:00 提供 Nasdaq GlobeNewswire
-
60 Degrees Pharmaceuticals Appoints Kristen Landon as Chief Commercial Officer
08 2 2024 07:59:00 提供 Nasdaq GlobeNewswire
-
60 Degrees Pharmaceuticals Announces Closing of $2.4 Million Public Offering
31 1 2024 11:15:00 提供 Nasdaq GlobeNewswire
-
60 Degrees Pharmaceuticals Announces Pricing of $2.4 Million Public Offering
30 1 2024 09:00:00 提供 Nasdaq GlobeNewswire
-
60 Degrees Pharma Plans Pivotal Babesiosis Study with Tafenoquine Following Jan 17 FDA Meeting
22 1 2024 07:59:00 提供 Nasdaq GlobeNewswire
-
60 Degrees Pharma Regains Compliance with Nasdaq Listing Requirements
16 1 2024 07:59:00 提供 Nasdaq GlobeNewswire
-
15 11 2023 07:29:00 提供 Nasdaq GlobeNewswire
-
19 10 2023 08:31:00 提供 Nasdaq GlobeNewswire
-
12 10 2023 16:16:00 提供 Nasdaq GlobeNewswire
-
18 9 2023 16:16:00 提供 Nasdaq GlobeNewswire
-
06 9 2023 07:31:00 提供 Nasdaq GlobeNewswire
-
30 8 2023 07:32:00 提供 Nasdaq GlobeNewswire
-
22 8 2023 07:31:00 提供 Nasdaq GlobeNewswire
-
15 8 2023 07:31:00 提供 Nasdaq GlobeNewswire
- <<
- <
- 1
- >